93 related articles for article (PubMed ID: 2802258)
1. Hypercoagulability in arterial disease.
Spillert CR; Milazzo VJ; Suval WD; Lazaro EJ
Angiology; 1989 Oct; 40(10):886-9. PubMed ID: 2802258
[TBL] [Abstract][Full Text] [Related]
2. Shortened endotoxin-activated clotting times in patients with carcinoma.
Spillert CR; Lazaro EJ
Am Surg; 1987 Mar; 53(3):164-6. PubMed ID: 3548512
[TBL] [Abstract][Full Text] [Related]
3. Modified recalcification time (MRT): a sensitive cancer test? Review of the evidence.
Spillert CR; Lazaro EJ
J Natl Med Assoc; 1995 Sep; 87(9):687-92. PubMed ID: 9583965
[TBL] [Abstract][Full Text] [Related]
4. Modified recalcification time: a global coagulation screening test.
Spillert CR; Lazaro EJ
J Natl Med Assoc; 1993 Aug; 85(8):611-6. PubMed ID: 8371283
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-induced necrosis: a monocyte-mediated hypercoagulable effect.
Spillert CR; Sun S; Ponnudurai R; Miller MA; Lazaro EJ
J Natl Med Assoc; 1995 Jul; 87(7):508-9. PubMed ID: 7636898
[TBL] [Abstract][Full Text] [Related]
6. Contribution of the monocyte to thrombotic potential.
Spillert CR; Lazaro EJ
Agents Actions; 1991 Sep; 34(1-2):28-9. PubMed ID: 1793044
[TBL] [Abstract][Full Text] [Related]
7. Recalcification time in breast disease.
Sofia CA; Spillert CR; Pastena JA; Lazaro EJ
J Natl Med Assoc; 1988 Nov; 80(11):1214-6. PubMed ID: 3249326
[TBL] [Abstract][Full Text] [Related]
8. Prediction of clinical course in diabetes using a simple coagulation test.
Spillert CR; Milazzo VJ; Pastena JA; Lazaro EJ
J Natl Med Assoc; 1989 Jan; 81(1):81-3. PubMed ID: 2724359
[TBL] [Abstract][Full Text] [Related]
9. Assessment of monocyte function in breast disease.
Spillert CR; Curtis GT; Lazaro EJ
South Med J; 1988 Feb; 81(2):164-6. PubMed ID: 3277286
[TBL] [Abstract][Full Text] [Related]
10. The production and availability of tissue thromboplastin in cellular populations of whole blood exposed to various concentrations of endotoxin. An assay for detection of endotoxin.
Osterud B; Bjørklid E
Scand J Haematol; 1982 Aug; 29(2):175-84. PubMed ID: 6813961
[TBL] [Abstract][Full Text] [Related]
11. Thrombin generation by exposure of blood to endotoxin: a simple model to study disseminated intravascular coagulation.
Stief TW
Clin Appl Thromb Hemost; 2006 Apr; 12(2):137-61. PubMed ID: 16708116
[TBL] [Abstract][Full Text] [Related]
12. Are hypertensives hypercoagulable?
Miller MA; Spillert CR; Ponnudurai R; Bonthu S; Lazaro EJ
J Natl Med Assoc; 1995 Jan; 87(1):71-2. PubMed ID: 7869410
[TBL] [Abstract][Full Text] [Related]
13. Thromboelastographic changes following nonionic contrast medium injection during transfemoral angiography in patients with peripheral arterial occlusive disease.
Shankar VK; Handa A; Philips-Hughes J; Boardman P; Uberoi R; Hands LJ
Cardiovasc Intervent Radiol; 2006; 29(6):1046-52. PubMed ID: 16810462
[TBL] [Abstract][Full Text] [Related]
14. Comparison of haemostatic parameters in arterial and venous blood from patients with peripheral arterial occlusive disease.
Woller T; Lawall H; Amann B; Angelkort B
Vasa; 1999 Feb; 28(1):10-4. PubMed ID: 10191700
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin-induced procoagulant activity in equine peripheral blood monocytes.
Henry MM; Moore JN
Circ Shock; 1988 Nov; 26(3):297-309. PubMed ID: 3208423
[TBL] [Abstract][Full Text] [Related]
16. Hypertension-related coronary thrombosis: prothrombic role of angiotensin II.
Spillert CR; Sun S; Miller MA; Lazaro EJ
J Natl Med Assoc; 1994 Sep; 86(9):686-8. PubMed ID: 7966432
[TBL] [Abstract][Full Text] [Related]
17. Routine tests as measures of the total intrinsic blood clotting potential. A comparison of whole blood clotting time (WBCT), recalcification time of citrated plasma (RTST), partial thromboplastin time (PTT), and activated partial thromboplastin time (APTT).
Korsan-Bengtsen K
Scand J Haematol; 1971; 8(5):359-68. PubMed ID: 4109186
[No Abstract] [Full Text] [Related]
18. Technical report: analysis of citrated blood with thromboelastography: comparison with fresh blood samples.
Wasowicz M; Srinivas C; Meineri M; Banks B; McCluskey SA; Karkouti K
Can J Anaesth; 2008 May; 55(5):284-9. PubMed ID: 18451116
[TBL] [Abstract][Full Text] [Related]
19. Deceptive prothrombin and activated partial thromboplastin times in alcoholic cirrhosis.
Sirikonda PR; Spillert CR; Koneru B; Ponnudurai R; Wilson DJ; Lazaro EJ
J Natl Med Assoc; 1996 May; 88(5):306-9. PubMed ID: 8667440
[TBL] [Abstract][Full Text] [Related]
20. Endogenous heparin activity is decreased in peripheral arterial occlusive disease.
Shankar VK; Handa A; Hands L
J Vasc Surg; 2008 May; 47(5):1033-8. PubMed ID: 18328667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
